A possible mechanism of mast cell proliferation in mastocytosis

Journal of Dermatology

Volumn 29, Issue 1, 2002, Pages 1-9

  Kambe, Naotomo ^a   Miyachi, Yoshiki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Human mast cells; Kit; Mastocytosis; Stem cell factor

Indexed keywords

STEM CELL FACTOR;

AUTOPHOSPHORYLATION; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; ERYTHRODERMA; MALIGNANT TRANSFORMATION; MAST CELL; MAST CELL LEUKEMIA; MASTOCYTOSIS; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PHENOTYPE; POINT MUTATION; REVIEW; URTICARIA PIGMENTOSA;

EID: 0036162814     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2002.tb00156.x     Document Type: Review

References (80)

1. Mast cell population density, blood vessel density and histamine content in normal human skin
2. Distribution of mast cells in human dermis: Development of a mapping technique
3. Mast cells in clinical dermatology
4. What is a physiological function of mast cells?
5. Critical protective role of mast cells in a model of acute septic peritonitis
6. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha
7. Impaired mast cell-dependent natural immunity in complement C3-deficient mice
8. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites
9. Effect of mast cell-derived mediators and mast cellrelated neutral proteases on human dermal fibroblast proliferation and type I collagen production
10. Human mast cells activate fibroblasts: Tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis
11. Production of febrogenic cytokines by cord blood-derived cultured human mast cells
12. Cord blood-derived human cultured mast cells produce transforming growth factor beta 1
13. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma
14. Human mast cells produce matrix metalloproteinase 9
15. Matrix metalloproteinase-9 production, a newly identified function of mast cell progenitors, is downregulated by c-kit receptor activation
16. Human tryptase fiborinogenolysis is optimal at acidic pH and generates anticoagulant fragments in the presence of the anti-tryptase monoclonal antibody B12
17. The skin in mastocytosis
18. Classification and diagnosis of mastocytosis: Current status
19. Systemic mast cell disease: Analysis of 58 cases and literature review
20. Mastocytosis: Recent advances in defining the disease
21. Urticaria pigmentosa: A review of 67 pediatric cases
22. Pediatric mastocytosis
23. Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis
24. Response to cyclosporin and low-dose methylprednisolone in aggressive systemic mastocytosis
25. Nerve growth factor release with mast-cell-derived mediators in a patient with systemic mastocytosis after middle-wave ultraviolet irradiation
26. Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand
27. Primary structure of c-kit: Relationship with the CSF-1/PDGF receptor kinase family - Oncogenic activation of vkit involves deletion of extracellular domain and C terminus
28. Expression of the YB5. B8 antigen (c-kit proto-oncogene product) in normal human bone marrow
29. Expression and function of c-kit in hemopoietic progenitor cells
30. Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: Functional properties and composite antigenic profile
31. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice - Evidence for an impaired c-kit kinase in mutant mice
32. Developmental expression of c-kit, a proto-oncogene encoded by the W locus
33. Expression of c-kit encoded at the W locus of mice in developing embryonic germ cells and presumptive melanoblasts
34. c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas
35. Gonadal expression of c-kit encoded at the W locus of the mouse
36. Disialoganglioside GD3 is selectively expressed by developing and mature human mast cells
37. Internalization of Kit together with stem cell factor on human fetal liver-derived mast cells: New protein and RNA synthesis are required for reappearance of Kit
38. The c-kit receptor ligand functions as a mast cell chemoattractant
39. Stem cell factor is a chemotactic factor for human mast cells
40. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils
41. Cord-blood-derived human cultured mast cells produce interleukin 13 in the presence of stem cell factor
42. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture
43. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand
44. Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells
45. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells
46. An improved procedure for the development of human mast cells from dispersed fetal liver cells in serum-free culture medium
47. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product
48. Establishment of an immature mast cell line from a patient with mast cell leukemia
49. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder
50. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: A possible explanation for divergent clinical behavior
51. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis
52. Effects of mutant c-kit in early myeloid cells
53. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines
54. Mechanisms of constitutive activation of c-kit receptor tyrosine kinase
55. Activating and dominant inactivating c-kit catalytic domain mutations in distinct clinical forms of human mastocytosis
56. Proliferation of peritoneal mast cells in the skin of W/Wv mice that genetically lack mast cells
57. Development of mucosal mast cells after injection of a single connective tissue-type mast cell in the stomach mucosa of genetically mast cell-deficient W/Wv mice
58. Extensive proliferation of mature connective tissue type mast cells in vitro
59. Proliferative potential of degranulated murine peritoneal mast cells
60. Formation of mast-cell colonies in methylcellulose by mouse skin cells and development of mucosal-like mast cells from the cloned cells in the gastric mucosa of W/Wv mice
61. Factors affecting the growth and maintenance of human skin mast cells in cell culture
62. Mast cell chemotactic activity of RANTES
63. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro
64. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines
65. Mast cell involvement in normal human skin wound healing: Expression of monocyte chemoattractant protein-I is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo
66. Human mast cell migration in response to members of the transforming growth factor-beta family
67. C3a and C5a stimulate chemotaxis of human mast cells
68. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis-toxin-sensitive signal transduction pathway
69. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo
70. Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes
71. Two types of human mast cells that have distinct neutral protease compositions
72. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies
73. Characterization of histamine secretion from mechanically dispersed human lung mast cells: Effects of anti-IgE, calcium ionophore A 23187, compound 48/80, and basic polypeptides
74. Isolation and characterization of human intestinal mucosal mast cells
75. The human cardiac mast cell: Localization, isolation, phenotype, and functional characterization
76. Altered metabolism of mast cell growth factor (c-kit ligand) in cutaneous mastocytosis
77. Expression of stem cell factor in cutaneous mastocytosis
78. Comparison of genetic and immunohistochemical findings in childhood and adult onset urticaria pigmentosa
79. Urticaria pigmentosa: A clinical, hematopathologic, and serologic study of 30 adults
80. Microdialysis in human skin